Net profit of Gujarat Terce Laboratories declined 5.41% to Rs 1.40 crore in the quarter ended September 2025 as against Rs 1.48 crore during the previous quarter ended September 2024. Sales declined 2.78% to Rs 12.93 crore in the quarter ended September 2025 as against Rs 13.30 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales12.9313.30 -3 OPM %14.6212.41 - PBDT1.881.60 18 PBT1.781.51 18 NP1.401.48 -5 Powered by Capital Market - Live News

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live News

Net Loss of Gujarat Terce Laboratories reported to Rs 0.04 crore in the quarter ended June 2025 as against net loss of Rs 0.08 crore during the previous quarter ended June 2024. Sales declined 8.75% to Rs 10.85 crore in the quarter ended June 2025 as against Rs 11.89 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales10.8511.89 -9 OPM %-0.090.67 - PBDT0.030.02 50 PBT-0.07-0.07 0 NP-0.04-0.08 50 Powered by Capital Market - Live News

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 11 August 2025.Powered by Capital Market - Live News

Gujarat Terce Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 21 August 2025.Powered by Capital Market - Live News